Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COmmencing Menopausal HOrmone Replacement Therapy and the Effect on Metabolic-dysfunction Associated Steatotic Liver Disease: a Pilot Mechanistic Study

NCT06704516 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT06704516
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06704516 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COmmencing Menopausal HOrmone Replacement Therapy and the Effect on Metabolic-dysfunction Associated Steatotic Liver Disease: a Pilot Mechanistic Study
Lead sponsor
University of Oxford
Phase
Phase 1
Overall status
Recruiting
Start date
January 31, 2025
Completion date
January 1, 2026
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

menopause, metabolic dysfunction associated steatotic liver disease